AN
50
-2
CF
48
-2
HOG
33
-2
PNW
66
6
SCHW
56
-2
RCL
76
3
ETR
55
3
MOS
38
-12
GRMN
45
-4
CNP
57
5
AFL
48
4
RSG
54
3
HCA
64
-2
ROP
35
-3
NWSA
71
-2
WYNN
49
15
MMM
57
-6
KLAC
70
3
LH
50
-3
MS
74
-2
AN
50
-2
CF
48
-2
HOG
33
-2
PNW
66
6
SCHW
56
-2
RCL
76
3
ETR
55
3
MOS
38
-12
GRMN
45
-4
CNP
57
5
AFL
48
4
RSG
54
3
HCA
64
-2
ROP
35
-3
NWSA
71
-2
WYNN
49
15
MMM
57
-6
KLAC
70
3
LH
50
-3
MS
74
-2
Financhill
Back

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison

Sell
42

VCIT
Vanguard Intermediate-Term Corp Bond Idx Fund ETF

Last Price:
$83.92
Seasonality Move:
-0.39%
Sell
41

AMPH
Amphastar Pharmaceuticals, Inc.

Last Price:
$25.63
Seasonality Move:
0.37%
Sell
42
Vanguard Intermediate-Term Corp Bond Idx Fund ETF (VCIT) is a Sell

Is Vanguard Intermediate-Term Corp Bond Idx Fund ETF a Buy, Sell or Hold?

  • The current Vanguard Intermediate-Term Corp Bond Idx Fund ETF [VCIT] share price is $83.79. The Score for VCIT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • VCIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Amphastar Pharmaceuticals, Inc. (AMPH) is a Sell

Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $26.31. The Score for AMPH is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • AMPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VCIT Stock Price Chart

What is Vanguard Intermediate-Term Corp Bond Idx Fund ETF's stock price today?

AMPH Stock Price Chart

What is Amphastar Pharmaceuticals, Inc.'s stock price today?

  • The Amphastar Pharmaceuticals, Inc. share price today is $26.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

VCIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 45.78 Sell
Chaikin Money Flow: -2700580 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.65 - 84.23) Sell
Bollinger Bands (100): (83.22 - 84.38) Sell

AMPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 51 Buy
Chaikin Money Flow: 281725 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.7 - 27.28) Sell
Bollinger Bands (100): (23.76 - 28.88) Sell

VCIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.87 Sell
20-day SMA: 83.98 Sell
50-day SMA: 84.08 Sell
200-day SMA: 82.63 Buy
8-day EMA: 83.88 Sell
20-day EMA: 83.95 Sell
50-day EMA: 82.26 Buy
200-day EMA: 52.1 Buy

AMPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.1 Buy
20-day SMA: 26.43 Sell
50-day SMA: 25.5 Buy
200-day SMA: 25.66 Buy
8-day EMA: 26.09 Buy
20-day EMA: 26.22 Buy
50-day EMA: 26.08 Buy
200-day EMA: 27.96 Sell

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Earnings Growth & VCIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and an increase next year of $0.29 per share.

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amphastar Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):